Capricor Therapeutics
CAPR
#7991
Rank
ยฃ0.21 B
Marketcap
ยฃ4.75
Share price
-4.36%
Change (1 day)
-59.16%
Change (1 year)

Capricor Therapeutics (CAPR) - Total assets

Total assets on the balance sheet as of September 2025 : ยฃ94.47 Million

According to Capricor Therapeutics 's latest financial reports the company's total assets are ยฃ94.47 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Capricor Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31ยฃ0.13 B194.67%
2023-12-31ยฃ46.1 M11.34%
2022-12-31ยฃ41.4 M35.24%
2021-12-31ยฃ30.61 M20.56%
2020-12-31ยฃ25.39 M199.67%
2019-12-31ยฃ8.47 M16.34%
2018-12-31ยฃ7.28 M-39.5%
2017-12-31ยฃ12.04 M-20.75%
2016-12-31ยฃ15.19 M40.11%
2015-12-31ยฃ10.84 M23.85%
2014-12-31ยฃ8.75 M160.8%
2013-12-31ยฃ3.35 M0.05%
2012-12-31ยฃ3.35 M280.09%
2011-12-31ยฃ0.88 M-62.82%
2010-12-31ยฃ2.37 M6.16%
2009-12-31ยฃ2.23 M-49.06%
2008-12-31ยฃ4.39 M-48.96%
2007-12-31ยฃ8.6 M
2006-12-31N/A-100%
2005-12-31ยฃ0 M-50.74%
2004-12-31ยฃ0 M-45.16%
2003-12-31ยฃ0 M3768.64%
2002-12-31ยฃ0 M-90.7%
2001-12-31ยฃ0 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Cytokinetics
CYTK
ยฃ1.07 B 1,036.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
ยฃ2.78 M-97.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ144.07 B 152,398.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ3.18 B 3,273.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
ยฃ0.48 B 412.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
ยฃ4.61 M-95.12%๐Ÿ‡บ๐Ÿ‡ธ USA